Thirty-three study patients were enrolled and received single-dose administration of 4 of the 6 treatments ( Placebo MDI , TIO 18 g , or GP MDI at 14.4 , 28.8 , 57.6 , and 115.2 g ex-actuator ) with an interval of 1 to 3 weeks between doses .